--- title: Associate a risk statement with a control objective in the Risk Workspace description: Associate risk statements to control objectives in the Risk Workspace. This association helps you to manage your risks by ensuring that the risks have mitigating controls. locale: en-US canonical_url: https://www.servicenow.com/docs/r/australia/governance-risk-compliance/grc-risk-management-workspace/create-control-objective-ws.html release: australia product: GRC: Risk Management Workspace classification: grc-risk-management-workspace topic_type: task last_updated: "2026-03-12" reading_time_minutes: 1 breadcrumb: [Use Risk Workspace, Risk Management, Governance, Risk, and Compliance] --- # Associate a risk statement with a control objective in the Risk Workspace Associate risk statements to control objectives in the Risk Workspace. This association helps you to manage your risks by ensuring that the risks have mitigating controls. ## Before you begin Role required: sn\_risk.manager or sn\_compliance.manager ## About this task When a control objective and risk statement are associated and the control entity matches the risk entity, the risk-control association is created. This association helps in mitigating the risks and threats. ## Procedure 1. Navigate to **All** > **Risk** > **Risk Workspace**. 2. In the Risk Workspace, select the list \[Omitted image "list-icon-risk-workspace.png"\] Alt text: List. icon. 3. Navigate to **Library** > **Control objectives**. 4. Select and open the required control objective. 5. Select the Risk statements related list. 1. Select **Add**. 2. Select the risk statements that you want to add. 3. Select **Add**. 4. Select **Save**. ## Result The risks associated with the risk statement automatically inherit the controls associated with the control objectives with matching entities. **Parent Topic:**[Using the Risk Workspace](https://raw.githubusercontent.com/ServiceNow/ServiceNowDocs/australia/markdown/australia/governance-risk-compliance/grc-risk-management-workspace/using-risk-workspace.md)